Evidence map›Paper›PMID 33202759›Full record

ArticleBiomolecules2020

Deciphering the Role of Positions 145 and 165 in Fluorescence Lifetime Shortening in the EGFP Variants.

Anastasia V Mamontova, Aleksander M Shakhov, Konstantin A Lukyanov, Alexey M Bogdanov

Abstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anastasia V MamontovaCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.ORCID 0000-0002-9255-6350
Aleksander M ShakhovSemenov Federal Research Center for Chemical Physics, 119991 Moscow, Russia.ORCID 0000-0002-0958-2903
Konstantin A LukyanovCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.ORCID 0000-0001-9845-2088
Alexey M BogdanovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.ORCID 0000-0002-5346-789X

Funding

Russian Foundation for Basic Research 19-34-60019Russian Science Foundation 20-14-00255
6 · The paper itself

Abstract

The bright ultimately short lifetime enhanced emitter (BrUSLEE) green fluorescent protein, which differs from the enhanced green fluorescent protein (EGFP) in three mutations, exhibits an extremely short fluorescence lifetime at a relatively high brightness. An important contribution to shortening the BrUSLEE fluorescence lifetime compared to EGFP is provided by the T65G substitution of chromophore-forming residue and the Y145M mutation touching the chromophore environment. Although the influence of the T65G mutation was studied previously, the role of the 145th position in determining the GFPs physicochemical characteristics remains unclear. In this work, we show that the Y145M substitution, both alone and in combination with the F165Y mutation, does not shorten the fluorescence lifetime of EGFP-derived mutants. Thus, the unlocking of Y145M as an important determinant of lifetime tuning is possible only cooperatively with mutations at position 65. We also show here that the introduction of a T65G substitution into EGFP causes complex photobehavior of the respective mutants in the lifetime domain, namely, the appearance of two fluorescent states with different lifetimes, preserved in any combination with the Y145M and F165Y substitutions.

Indexed as

Mutation, MissenseAmino Acid MotifsFluorescenceGreen Fluorescent ProteinsHeLa CellsHumansKineticsSpectrometry, Fluorescenceenhanced green fluorescent proteinGreen Fluorescent Proteinschromophorefluorescence lifetimefluorescence spectroscopyfluorescent proteinsGFPoscillator strengthphotostabilityquantum efficiency

Identifiers

PMID33202759
PMCPMC7696298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.